LOGIN
ID
PW
MemberShip
2025-07-01 08:53
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review
of Major Trends
Input Time : 2019-11-15
[Download file]
go back
OPINION
[Reporter's View] Divisional restructuring needed
Reporter's view |
Lee, Hye-Kyung
[Reporter's View] For local gov't seeking biotech diplomacy
Reporter's view |
Whang, byung-woo
[Reporter's View] Silent efforts pay off in the market
Reporter's view |
Son, Hyung Min
INTERVIEW
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Hemlibra shows long-term efficacy and safety in hemophilia
Long-term prevention of bleeding episodes
"High hopes for reimbursed Ilaris¡¦a new treatment option"
Dr. Soyoung Lee, Professor of Pediatric & Adolescent Medicine at Hallym University Sacred Heart Hospital
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Adempas may be prescribed at general hospitals in KOR
2
More generic 'Vimovo' drugs with naproxen+PPI enters the mkt
3
Polivy granted partial reimbursement after 5 years
4
[Reporter's View] Divisional restructuring needed
5
New K-drugs for metabolic diseases make international debut
6
[Reporter's View] For local gov't seeking biotech diplomacy
7
Dong-A ST-Ipsen to comarket prostate cancer drug Diphereline
8
Asthma drug 'Trelegy 200 Ellipta Inhaler' becomes available
9
Metabolic disease drug development landscape evolves
10
AstraZeneca Korea launches ¡®Lung Health Checkbus¡¯ campaign